Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Amino sugar and nucleotide sugar metabolism	8/48	2.3251910987207885E-5	0.007161588584060029	0	0	6.640106241699867	70.84411179488964	CYB5R1;UGDH;CYB5R4;NAGK;FPGT;HEXA;PGM2;GALK1
SNARE interactions in vesicular transport	5/34	0.0014890609251297267	0.2293153824699779	0	0	5.858917272088118	38.139264174522964	SNAP23;STX7;STX6;STX1A;BET1
Propanoate metabolism	4/32	0.008081841902926212	0.8297357687004245	0	0	4.9800796812749	23.994698576417967	ECHS1;ECHDC1;SUCLG1;ACAT1
DNA replication	4/36	0.01223996416617629	0.9424772407955744	0	0	4.426737494466578	19.491141786198398	POLA2;RNASEH2A;PCNA;RPA3
Riboflavin metabolism	2/8	0.015925324055525752	0.9809999618203863	0	0	9.9601593625498	41.23351323581001	FLAD1;RFK
Lysine degradation	5/59	0.016090665535268993	0.8259874974771416	0	0	3.376325207644	13.942588816082965	SETD3;ECHS1;DOT1L;HADH;ACAT1
Fatty acid degradation	4/44	0.02413465585950812	1.0	0	0	3.621876131836291	13.488252332313431	ECHS1;ECI1;HADH;ACAT1
Apoptosis	8/143	0.028036124357610975	1.0	0	0	2.2288468503607946	7.9664813634159595	ERN1;NGFR;TUBA1B;TNFSF10;FADD;TRAF1;EIF2S1;CTSC
Collecting duct acid secretion	3/27	0.029417015980636684	1.0	0	0	4.426737494466578	15.609482059369098	ATP6V1E1;ATP6V1D;ATP6V1C1
Ubiquinone and other terpenoid-quinone biosynthesis	2/11	0.029765909159487694	0.916790002112221	0	0	7.243752263672582	25.457381588273158	COQ2;COQ5
Thermogenesis	11/231	0.03208900682184568	0.898492191011679	0	0	1.8971732119142477	6.524837363138715	COA3;CREB3;COX7B;NDUFB6;ACTL6A;PRKAG1;NDUFAF3;NDUFC2;SDHD;SLC25A20;COA6
Butanoate metabolism	3/28	0.03234963274149071	0.8303072403649283	0	0	4.2686397268070575	14.646354343020972	ECHS1;HADH;ACAT1
Phagosome	8/152	0.038207129508367584	0.9052150683520934	0	0	2.0968756552736423	6.845739451539741	TUBA1B;FCGR3B;CD209;STX7;ATP6V1E1;ATP6V1D;ATP6V1C1;HLA-DPA1
Circadian rhythm	3/31	0.042022440561629244	0.9244936923558434	0	0	3.8555455596966968	12.220350228631123	PER1;PRKAG1;NR1D1
Base excision repair	3/33	0.04918512526743704	1.0	0	0	3.621876131836291	10.909685016870908	PCNA;MPG;NTHL1
Oxidative phosphorylation	7/133	0.05064083959150571	0.9748361621364849	0	0	2.0968756552736423	6.2549736248114165	COX7B;NDUFB6;NDUFC2;SDHD;ATP6V1E1;ATP6V1D;ATP6V1C1
Pyrimidine metabolism	4/57	0.054652697605553927	0.9901782860300358	0	0	2.7958342070315227	8.126809824800537	UCK2;PNP;NME6;DCK
Selenocompound metabolism	2/17	0.06670731126541286	1.0	0	0	4.687133817670494	12.690136948177397	TXNRD3;TXNRD1
Other glycan degradation	2/18	0.07383485953290411	1.0	0	0	4.426737494466578	11.535742839770466	FUCA1;HEXA
Pyruvate metabolism	3/39	0.07391962462766026	1.0	0	0	3.0646644192460926	7.9827671766797845	ACYP2;ME2;ACAT1
Rheumatoid arthritis	5/91	0.07892026670400036	1.0	0	0	2.189046013747209	5.55868223460275	TGFB3;ATP6V1E1;ATP6V1D;ATP6V1C1;HLA-DPA1
Pantothenate and CoA biosynthesis	2/19	0.0811928360183098	1.0	0	0	4.193751310547285	10.53020868979734	PANK2;AASDHPPT
Steroid biosynthesis	2/19	0.0811928360183098	1.0	0	0	4.193751310547285	10.53020868979734	CYP27B1;NSDHL
Non-alcoholic fatty liver disease (NAFLD)	7/149	0.08200729828782993	1.0	0	0	1.871707799673788	4.681042066680495	ERN1;COX7B;NDUFB6;PRKAG1;NDUFC2;SDHD;EIF2S1
Tuberculosis	8/179	0.08246274353703474	1.0	0	0	1.7805871486122549	4.443292628157385	TLR1;CYP27B1;FCGR3B;TGFB3;CD209;FADD;CAMP;HLA-DPA1
Porphyrin and chlorophyll metabolism	3/42	0.08798577820220385	1.0	0	0	2.8457598178713712	6.916847151118504	UROD;UROS;CPOX
Tryptophan metabolism	3/42	0.08798577820220385	1.0	0	0	2.8457598178713712	6.916847151118504	ECHS1;HADH;ACAT1
Epithelial cell signaling in Helicobacter pylori infection	4/68	0.09138437368030057	1.0	0	0	2.343566908835247	5.607407502782088	CXCR2;ATP6V1E1;ATP6V1D;ATP6V1C1
Vasopressin-regulated water reabsorption	3/44	0.09793900892150492	1.0	0	0	2.716407098877218	6.311328373778941	DYNC2LI1;CREB3;DYNLL1
Wnt signaling pathway	7/158	0.10365143895405136	1.0	0	0	1.7650915326037622	4.0009710277001655	FOSL1;RNF43;WNT10B;FRAT2;FZD2;RAC3;PPARD
Terpenoid backbone biosynthesis	2/22	0.10449254633741342	1.0	0	0	3.621876131836291	8.180512629611954	ICMT;ACAT1
Mismatch repair	2/23	0.11261863416387509	1.0	0	0	3.464403256539061	7.565383984266103	PCNA;RPA3
Proximal tubule bicarbonate reclamation	2/23	0.11261863416387509	1.0	0	0	3.464403256539061	7.565383984266103	SLC9A3;GLS2
Inositol phosphate metabolism	4/74	0.11530177408417508	1.0	0	0	2.1535479702810383	4.652099634210721	FIG4;MINPP1;ISYNA1;INPP5E
Valine, leucine and isoleucine degradation	3/48	0.11911287989291455	1.0	0	0	2.49003984063745	5.298017094000589	ECHS1;HADH;ACAT1
D-Glutamine and D-glutamate metabolism	1/5	0.11936706069898596	1.0	0	0	7.968127490039841	16.93666924005237	GLS2
RNA transport	7/165	0.12241875587534602	1.0	0	0	1.6902088615236026	3.549958663424283	EIF2B2;NUP50;RPP40;NUPL2;EIF2S1;THOC7;SNUPN
Arginine and proline metabolism	3/49	0.12465120790261948	1.0	0	0	2.439222701032604	5.079036780320939	CARNS1;PYCR2;LAP3
Malaria	3/49	0.12465120790261948	0.9844249239488922	0	0	2.439222701032604	5.079036780320939	TGFB3;HBB;HBA2
Vibrio cholerae infection	3/50	0.13028079457839345	1.0	0	0	2.390438247011952	4.871864222121594	ATP6V1E1;ATP6V1D;ATP6V1C1
Hepatocellular carcinoma	7/168	0.1309605044124727	0.9838008624156485	0	0	1.6600265604249667	3.374600754106419	WNT10B;FRAT2;FZD2;TXNRD3;TGFB3;TXNRD1;ACTL6A
Synaptic vesicle cycle	4/78	0.13261172640855165	0.9724859936627122	0	0	2.0431096128307282	4.12775517557838	ATP6V1E1;ATP6V1D;STX1A;ATP6V1C1
Mineral absorption	3/51	0.13599827034748127	0.9741271457447497	0	0	2.343566908835247	4.675681067167063	SLC9A3;SLC40A1;SLC30A1
Alzheimer disease	7/171	0.13979125382552468	0.9785387767786727	0	0	1.6309032874350549	3.208973484383135	ERN1;COX7B;NDUFB6;NDUFC2;SDHD;APOE;FADD
Fatty acid elongation	2/27	0.14656361179373656	1.0	0	0	2.951158329644385	5.667096752459284	ECHS1;HADH
Pathogenic Escherichia coli infection	3/55	0.15967957356635804	1.0	0	0	2.1731256791017746	3.986786244782138	TUBA1B;ARPC1A;LY96
Citrate cycle (TCA cycle)	2/30	0.17320220700672326	1.0	0	0	2.6560424966799467	4.6568274645469945	SUCLG1;SDHD
Galactose metabolism	2/31	0.18224909073322165	1.0	0	0	2.5703637064644647	4.375738072802829	PGM2;GALK1
RNA polymerase	2/31	0.18224909073322165	1.0	0	0	2.5703637064644647	4.375738072802829	POLR3C;POLR3K
beta-Alanine metabolism	2/31	0.18224909073322165	1.0	0	0	2.5703637064644647	4.375738072802829	ECHS1;CARNS1
Sulfur relay system	1/8	0.18404704593506174	1.0	0	0	4.9800796812749	8.429102936380286	CTU2
AMPK signaling pathway	5/120	0.18409755558795657	1.0	0	0	1.6600265604249667	2.80924546557638	RAB10;PFKFB1;CREB3;PPP2CB;PRKAG1
Fructose and mannose metabolism	2/33	0.20053626220149043	1.0	0	0	2.414584087890861	3.8796575871742216	PFKFB1;FPGT
Chemokine signaling pathway	7/190	0.20184890411877715	1.0	0	0	1.4678129586915494	2.348846933568562	CCR1;CX3CR1;CXCR2;GNB4;RAC3;CCR5;CCR2
Sulfur metabolism	1/9	0.2045356318359021	1.0	0	0	4.426737494466578	7.025290304872648	BPNT1
Cytokine-cytokine receptor interaction	10/294	0.206271324295962	1.0	0	0	1.3551237227958914	2.1391479911454896	CCR1;CX3CR1;NGFR;GDF9;TGFB3;CXCR2;TNFSF10;CCR5;IL17C;CCR2
Hippo signaling pathway	6/160	0.21474881331525383	1.0	0	0	1.4940239043824701	2.298236420352234	WNT10B;PPP2CB;FZD2;TGFB3;TP73;YWHAH
Synthesis and degradation of ketone bodies	1/10	0.22451074812755697	1.0	0	0	3.9840637450199203	5.951520705574745	ACAT1
Protein processing in endoplasmic reticulum	6/165	0.23497728416171473	1.0	0	0	1.4487504527345163	2.0981766499844983	ERN1;LMAN2;FBXO6;EIF2S1;RNF185;UBQLN4
African trypanosomiasis	2/37	0.23764451565107203	1.0	0	0	2.1535479702810383	3.0946039702997306	HBB;HBA2
Staphylococcus aureus infection	3/68	0.24341914275522333	1.0	0	0	1.7576751816264355	2.4835430997387635	FCGR3B;CAMP;HLA-DPA1
Tight junction	6/170	0.2557645584559421	1.0	0	0	1.4061401453011484	1.917269207234538	PPP2CB;TUBA1B;PCNA;PRKAG1;MYH11;MYL6B
Glucagon signaling pathway	4/103	0.25938817669719344	1.0	0	0	1.5472092213669593	2.0878499014635343	PFKFB1;CREB3;PPP4C;PRKAG1
Homologous recombination	2/41	0.2750632914923082	1.0	0	0	1.9434457292780098	2.508510459459909	RAD51C;RPA3
Leishmaniasis	3/74	0.28420107928400484	1.0	0	0	1.6151609777107785	2.0319908458677785	FCGR3B;TGFB3;HLA-DPA1
Toxoplasmosis	4/113	0.31554639919635485	1.0	0	0	1.410288051334485	1.6266961072035613	TGFB3;LY96;CCR5;HLA-DPA1
Nucleotide excision repair	2/47	0.3309061737612947	1.0	0	0	1.6953462744765617	1.8749180414429183	PCNA;RPA3
mTOR signaling pathway	5/152	0.3344810756507666	1.0	0	0	1.3105472845460262	1.4352785909642467	WNT10B;FZD2;ATP6V1E1;ATP6V1D;ATP6V1C1
Human cytomegalovirus infection	7/225	0.33620543757523447	1.0	0	0	1.2394864984506417	1.3510810432123321	CCR1;CREB3;CXCR2;GNB4;RAC3;FADD;CCR5
Primary bile acid biosynthesis	1/17	0.3509988226073998	1.0	0	0	2.343566908835247	2.453649894344433	HSD17B4
N-Glycan biosynthesis	2/50	0.3584083289675723	1.0	0	0	1.593625498007968	1.6351910101108331	DPAGT1;MGAT2
Glycosaminoglycan degradation	1/19	0.3831975660189228	1.0	0	0	2.0968756552736423	2.0113327419390923	HEXA
Hepatitis B	5/163	0.3892630331116218	1.0	0	0	1.2221054432576441	1.1530564688533833	CREB3;PCNA;TGFB3;FADD;HSPG2
Fanconi anemia pathway	2/54	0.3944045080130756	1.0	0	0	1.4755791648221925	1.3728467260816617	RAD51C;RPA3
mRNA surveillance pathway	3/91	0.40085099625845144	1.0	0	0	1.3134276082483254	1.2006902076943256	PPP2CB;CPSF2;SMG6
Autophagy	4/128	0.40105699959737484	1.0	0	0	1.245019920318725	1.137514589321048	ERN1;PPP2CB;ATG4C;EIF2S1
Purine metabolism	4/129	0.40672466907588023	1.0	0	0	1.235368603106952	1.1113608341435623	PNP;NME6;PGM2;DCK
Glutathione metabolism	2/56	0.41205745985421527	1.0	0	0	1.4228799089356856	1.2615146182291852	GGCT;LAP3
Arginine biosynthesis	1/21	0.4138018615717043	1.0	0	0	1.8971732119142477	1.6740049610273324	GLS2
Endocytosis	7/244	0.4140130951284056	1.0	0	0	1.142969107177846	1.0079360793522405	RAB10;DAB2;ARPC1A;CXCR2;CCR5;SNX5;CHMP5
IL-17 signaling pathway	3/93	0.41434349418367394	1.0	0	0	1.2851818532322323	1.1323222632933165	FOSL1;FADD;IL17C
Natural killer cell mediated cytotoxicity	4/131	0.41802755042240936	1.0	0	0	1.2165080137465405	1.0610479468725382	FCGR3B;TNFSF10;RAC3;CD244
Viral myocarditis	2/59	0.4380470709255914	1.0	0	0	1.3505300830576001	1.114766569671553	RAC3;HLA-DPA1
Glycerophospholipid metabolism	3/97	0.4410228598191859	1.0	0	0	1.2321846634082227	1.0087385327400449	LYPLA1;ETNK2;PLA2G6
Histidine metabolism	1/23	0.4428905146593787	1.0	0	0	1.7322016282695305	1.410761622589367	CARNS1
Measles	4/138	0.45714420204410444	1.0	0	0	1.1548010855130204	0.9039279372740708	CD209;FADD;EIF2S1;TP73
Melanogenesis	3/101	0.46722102534613474	1.0	0	0	1.183385270797996	0.9005003892541958	WNT10B;CREB3;FZD2
Ribosome biogenesis in eukaryotes	3/101	0.46722102534613474	1.0	0	0	1.183385270797996	0.9005003892541958	UTP6;RPP40;HEATR1
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	1/25	0.4705384432580249	1.0	0	0	1.593625498007968	1.2013985913165683	PIGL
alpha-Linolenic acid metabolism	1/25	0.4705384432580249	1.0	0	0	1.593625498007968	1.2013985913165683	PLA2G6
Arachidonic acid metabolism	2/63	0.4716983835211971	1.0	0	0	1.264782141276165	0.9503769248329189	PLA2G6;CBR3
Basal cell carcinoma	2/63	0.4716983835211971	1.0	0	0	1.264782141276165	0.9503769248329189	WNT10B;FZD2
Cytosolic DNA-sensing pathway	2/63	0.4716983835211971	1.0	0	0	1.264782141276165	0.9503769248329189	POLR3C;POLR3K
Parkinson disease	4/142	0.47910111421723506	1.0	0	0	1.1222714774704001	0.8258162947637859	COX7B;NDUFB6;NDUFC2;SDHD
Chagas disease (American trypanosomiasis)	3/103	0.48011496222122657	1.0	0	0	1.1604069160252195	0.8514250173627428	PPP2CB;TGFB3;FADD
Folate biosynthesis	1/26	0.4838445319937499	1.0	0	0	1.5323322096230463	1.1124603719813124	GGH
Maturity onset diabetes of the young	1/26	0.4838445319937499	1.0	0	0	1.5323322096230463	1.1124603719813124	HHEX
Toll-like receptor signaling pathway	3/104	0.486506775637876	1.0	0	0	1.1492491572172847	0.8280391320945291	TLR1;LY96;FADD
Inflammatory bowel disease (IBD)	2/65	0.48806444557582374	1.0	0	0	1.225865767698437	0.8793231029629518	TGFB3;HLA-DPA1
Ascorbate and aldarate metabolism	1/27	0.4968168690869683	1.0	0	0	1.4755791648221925	1.0322174907042585	UGDH
Biosynthesis of unsaturated fatty acids	1/27	0.4968168690869683	1.0	0	0	1.4755791648221925	1.0322174907042585	HSD17B4
Transcriptional misregulation in cancer	5/186	0.5017145406416932	1.0	0	0	1.070984877693527	0.7386839364797347	NGFR;HHEX;DOT1L;TRAF1;FLI1
Phototransduction	1/28	0.5094638096731188	1.0	0	0	1.4228799089356856	0.9595851734572252	RCVRN
Retrograde endocannabinoid signaling	4/148	0.511362051415867	1.0	0	0	1.0767739851405191	0.7221680027631159	NDUFB6;GNB4;NDUFC2;ABHD6
Amphetamine addiction	2/68	0.5120095274366109	1.0	0	0	1.1717834544176235	0.7844059595044884	CREB3;STX1A
Glycolysis / Gluconeogenesis	2/68	0.5120095274366109	1.0	0	0	1.1717834544176235	0.7844059595044884	MINPP1;PGM2
Gastric cancer	4/149	0.5166512325273824	1.0	0	0	1.0695473140993075	0.7063153888722097	WNT10B;FRAT2;FZD2;TGFB3
Linoleic acid metabolism	1/29	0.5217934999393405	1.0	0	0	1.3738150844896275	0.8936438567844196	PLA2G6
TNF signaling pathway	3/110	0.5240249563332057	1.0	0	0	1.0865628395508873	0.7021542584626416	CREB3;FADD;TRAF1
Glyoxylate and dicarboxylate metabolism	1/30	0.5338138827289893	1.0	0	0	1.3280212483399734	0.8336096082197666	ACAT1
Nicotinate and nicotinamide metabolism	1/30	0.5338138827289893	1.0	0	0	1.3280212483399734	0.8336096082197666	PNP
Pentose phosphate pathway	1/30	0.5338138827289893	1.0	0	0	1.3280212483399734	0.8336096082197666	PGM2
Huntington disease	5/193	0.534441275735034	1.0	0	0	1.0321408665854714	0.6466707493489594	CREB3;COX7B;NDUFB6;NDUFC2;SDHD
B cell receptor signaling pathway	2/71	0.5352062268716424	1.0	0	0	1.1222714774704001	0.7015354195306566	RAC3;DAPP1
Ribosome	4/153	0.5375348306917285	1.0	0	0	1.0415852928156655	0.6465762776792389	MRPS11;MRPL14;MRPL36;MRPL13
Asthma	1/31	0.5455327023617175	1.0	0	0	1.2851818532322323	0.7788105978304376	HLA-DPA1
Cushing syndrome	4/155	0.5478049999369462	1.0	0	0	1.0281454825857859	0.6187748565903103	WNT10B;CREB3;FZD2;ASH2L
Hepatitis C	4/155	0.5478049999369462	1.0	0	0	1.0281454825857859	0.6187748565903103	PPP2CB;FADD;EIF2S1;YWHAH
Pancreatic cancer	2/75	0.564938534030731	1.0	0	0	1.0624169986719787	0.6066808425814861	TGFB3;RAC3
Pathways in cancer	13/530	0.5734269622505982	1.0	0	0	0.9772231827407352	0.5434579541472859	ALK;WNT10B;FZD2;TXNRD3;TGFB3;TXNRD1;TRAF1;FRAT2;LPAR6;GNB4;RAC3;FADD;PPARD
Pentose and glucuronate interconversions	1/34	0.5789543510943835	1.0	0	0	1.1717834544176235	0.6404167394651923	UGDH
Human papillomavirus infection	8/330	0.5894097446182469	1.0	0	0	0.9658336351563442	0.510572184667161	WNT10B;PPP2CB;CREB3;FZD2;FADD;ATP6V1E1;ATP6V1D;ATP6V1C1
Alanine, aspartate and glutamate metabolism	1/35	0.5895405621191011	1.0	0	0	1.1383039271485487	0.6014931743948324	GLS2
Lysosome	3/123	0.5998085323664377	1.0	0	0	0.9717228646390049	0.4966910770730677	FUCA1;HEXA;CTSC
Starch and sucrose metabolism	1/36	0.5998611235063278	1.0	0	0	1.1066843736166445	0.5655789191898716	PGM2
Tyrosine metabolism	1/36	0.5998611235063278	1.0	0	0	1.1066843736166445	0.5655789191898716	FAHD1
Cell cycle	3/124	0.6053004074090286	1.0	0	0	0.9638863899241742	0.48390027279442466	PCNA;TGFB3;YWHAH
Human immunodeficiency virus 1 infection	5/212	0.6178366603137377	1.0	0	0	0.9396376757122454	0.4524648201141455	APOBEC3G;GNB4;RAC3;FADD;CCR5
Allograft rejection	1/38	0.6197317435458374	1.0	0	0	1.0484378276368211	0.5016445442154229	HLA-DPA1
Peroxisome	2/83	0.6202194047003833	1.0	0	0	0.960015360245764	0.458582042907157	HSD17B4;DECR2
Hypertrophic cardiomyopathy (HCM)	2/85	0.6331653091561008	1.0	0	0	0.9374267635340988	0.4284262845341565	TGFB3;PRKAG1
Ferroptosis	1/40	0.6386174659783542	1.0	0	0	0.9960159362549801	0.44666299666857434	SLC40A1
Colorectal cancer	2/86	0.6395079294493041	1.0	0	0	0.926526452330214	0.4142094492620244	TGFB3;RAC3
Insulin secretion	2/86	0.6395079294493041	1.0	0	0	0.926526452330214	0.4142094492620244	CREB3;STX1A
Dopaminergic synapse	3/131	0.6423279965721623	1.0	0	0	0.9123810103099054	0.40387111797271025	CREB3;PPP2CB;GNB4
FoxO signaling pathway	3/132	0.6474132774054968	1.0	0	0	0.9054690329590728	0.3936711598038362	TGFB3;TNFSF10;PRKAG1
Vascular smooth muscle contraction	3/132	0.6474132774054968	1.0	0	0	0.9054690329590728	0.3936711598038362	MYH11;MYL6B;PLA2G6
Graft-versus-host disease	1/41	0.6477063123693946	1.0	0	0	0.9717228646390049	0.42203664077155456	HLA-DPA1
GABAergic synapse	2/89	0.6580181484507561	1.0	0	0	0.895295223599982	0.3747014340883861	GLS2;GNB4
Protein digestion and absorption	2/90	0.6640169219941664	1.0	0	0	0.8853474988933157	0.3625034483394998	COL18A1;SLC9A3
Salivary secretion	2/90	0.6640169219941664	1.0	0	0	0.8853474988933157	0.3625034483394998	PRH2;CAMP
TGF-beta signaling pathway	2/90	0.6640169219941664	1.0	0	0	0.8853474988933157	0.3625034483394998	PPP2CB;TGFB3
Type I diabetes mellitus	1/43	0.6652052899777658	1.0	0	0	0.926526452330214	0.377707383705105	HLA-DPA1
Axon guidance	4/181	0.6693444630834215	1.0	0	0	0.8804560762474961	0.3534647785557798	ABLIM2;RAC3;SRGAP3;EPHA1
Fc gamma R-mediated phagocytosis	2/91	0.6699307575210326	1.0	0	0	0.8756184054988836	0.35075602549916923	ARPC1A;PLA2G6
Estrogen signaling pathway	3/137	0.6720669912486296	1.0	0	0	0.8724227178875738	0.34669839247642564	NCOA2;CREB3;KRT23
Glycosphingolipid biosynthesis	1/45	0.6818367068788906	1.0	0	0	0.8853474988933157	0.3390571779868671	HEXA
Kaposi sarcoma-associated herpesvirus infection	4/186	0.6899552133479699	1.0	0	0	0.8567879021548216	0.3179784875027269	CCR1;GNB4;FADD;CCR5
NF-kappa B signaling pathway	2/95	0.6927466591791837	1.0	0	0	0.8387502621094569	0.3078976035224767	LY96;TRAF1
Ras signaling pathway	5/232	0.6953667077495951	1.0	0	0	0.8586344278060173	0.3119555704072077	NGFR;RASGRF2;GNB4;RAC3;PLA2G6
Ether lipid metabolism	1/47	0.6976434933264625	1.0	0	0	0.8476731372382809	0.30520222195974733	PLA2G6
Circadian entrainment	2/97	0.7036586664212187	1.0	0	0	0.8214564422721484	0.28871063312506084	PER1;GNB4
Intestinal immune network for IgA production	1/48	0.7052504830921559	1.0	0	0	0.8300132802124833	0.28984250008804047	HLA-DPA1
Cell adhesion molecules (CAMs)	3/145	0.7088371967562029	1.0	0	0	0.8242890506937766	0.28366209856411556	NLGN3;NLGN2;HLA-DPA1
Cocaine addiction	1/49	0.712666459036533	1.0	0	0	0.8130742336775346	0.27542220294972125	CREB3
Choline metabolism in cancer	2/99	0.714246500876945	1.0	0	0	0.804861362630287	0.2708576899677917	LYPLA1;RAC3
Breast cancer	3/147	0.7175193448610826	1.0	0	0	0.8130742336775346	0.2699043582673016	WNT10B;FRAT2;FZD2
Inflammatory mediator regulation of TRP channels	2/100	0.719420483930687	1.0	0	0	0.796812749003984	0.26239782828224795	PLA2G6;ASIC3
Cholesterol metabolism	1/50	0.7198962082365057	1.0	0	0	0.796812749003984	0.26187110166571703	APOE
Longevity regulating pathway	2/102	0.729531998414903	1.0	0	0	0.781188969611749	0.24634954182697713	CREB3;PRKAG1
Autoimmune thyroid disease	1/53	0.7405141878301185	1.0	0	0	0.7517101405697962	0.2258216084042968	HLA-DPA1
Viral carcinogenesis	4/201	0.7462416275704226	1.0	0	0	0.7928485064716259	0.23207138306426398	CREB3;TRAF1;CCR5;YWHAH
Parathyroid hormone synthesis, secretion and action	2/106	0.748829299232347	1.0	0	0	0.7517101405697962	0.21742781803797492	CYP27B1;CREB3
Drug metabolism	2/108	0.7580270077923303	1.0	0	0	0.7377895824110963	0.20439446926488192	UCK2;NME6
Insulin resistance	2/108	0.7580270077923303	1.0	0	0	0.7377895824110963	0.20439446926488192	CREB3;PRKAG1
Cholinergic synapse	2/112	0.7755515190773224	1.0	0	0	0.7114399544678428	0.1808344231670295	CREB3;GNB4
Necroptosis	3/162	0.7763301623787681	1.0	0	0	0.7377895824110963	0.18679163516407093	TNFSF10;FADD;CHMP5
VEGF signaling pathway	1/59	0.7773166445190685	1.0	0	0	0.6752650415288001	0.17010432151085478	RAC3
Long-term depression	1/60	0.7829224954058359	1.0	0	0	0.6640106241699867	0.16249772380252944	PPP2CB
Glutamatergic synapse	2/114	0.7838910575159088	1.0	0	0	0.6989585517578807	0.17018608061599122	GLS2;GNB4
Human T-cell leukemia virus 1 infection	4/219	0.8030873554400999	1.0	0	0	0.7276828758027251	0.15957487645827567	FOSL1;CREB3;TGFB3;HLA-DPA1
Neurotrophin signaling pathway	2/119	0.8035589806131443	1.0	0	0	0.6695905453814992	0.14644259391164385	NGFR;TP73
Sphingolipid signaling pathway	2/119	0.8035589806131443	1.0	0	0	0.6695905453814992	0.14644259391164385	PPP2CB;RAC3
Influenza A	3/171	0.8065371690859053	1.0	0	0	0.6989585517578807	0.15027979001714792	TNFSF10;EIF2S1;HLA-DPA1
Central carbon metabolism in cancer	1/65	0.8089083362912011	1.0	0	0	0.6129328838492185	0.12998447643174305	GLS2
Cortisol synthesis and secretion	1/65	0.8089083362912011	1.0	0	0	0.6129328838492185	0.12998447643174305	CREB3
Mitophagy	1/65	0.8089083362912011	1.0	0	0	0.6129328838492185	0.12998447643174305	FUNDC1
Shigellosis	1/65	0.8089083362912011	1.0	0	0	0.6129328838492185	0.12998447643174305	ARPC1A
Acute myeloid leukemia	1/66	0.8137203357344184	1.0	0	0	0.6036460219727152	0.12443470958976345	PPARD
Aminoacyl-tRNA biosynthesis	1/66	0.8137203357344184	1.0	0	0	0.6036460219727152	0.12443470958976345	TARS
Non-small cell lung cancer	1/66	0.8137203357344184	1.0	0	0	0.6036460219727152	0.12443470958976345	ALK
Fc epsilon RI signaling pathway	1/68	0.822984548204944	1.0	0	0	0.5858917272088118	0.11414216864596617	RAC3
Oocyte meiosis	2/125	0.825050646259852	1.0	0	0	0.6374501992031872	0.12258836980132416	PPP2CB;YWHAH
Adipocytokine signaling pathway	1/69	0.8274427527614313	1.0	0	0	0.5774005427565102	0.10936852882786806	PRKAG1
Renal cell carcinoma	1/69	0.8274427527614313	1.0	0	0	0.5774005427565102	0.10936852882786806	TGFB3
Osteoclast differentiation	2/127	0.8317313974317198	1.0	0	0	0.6274116133889638	0.11559791066298326	FOSL1;FCGR3B
RIG-I-like receptor signaling pathway	1/70	0.8317888922968684	1.0	0	0	0.5691519635742743	0.10482447670874553	FADD
Adherens junction	1/72	0.8401561521102231	1.0	0	0	0.5533421868083223	0.09637423032971872	RAC3
Bile secretion	1/72	0.8401561521102231	1.0	0	0	0.5533421868083223	0.09637423032971872	SLC9A3
p53 signaling pathway	1/72	0.8401561521102231	1.0	0	0	0.5533421868083223	0.09637423032971872	TP73
Relaxin signaling pathway	2/130	0.8413218490841372	1.0	0	0	0.6129328838492185	0.10590315301304312	CREB3;GNB4
Bacterial invasion of epithelial cells	1/74	0.8481079850898541	1.0	0	0	0.5383869925702596	0.08869780897467017	ARPC1A
Metabolism of xenobiotics by cytochrome P450	1/74	0.8481079850898541	1.0	0	0	0.5383869925702596	0.08869780897467017	CBR3
PPAR signaling pathway	1/74	0.8481079850898541	1.0	0	0	0.5383869925702596	0.08869780897467017	PPARD
Thyroid hormone synthesis	1/74	0.8481079850898541	1.0	0	0	0.5383869925702596	0.08869780897467017	CREB3
Systemic lupus erythematosus	2/133	0.8504146339187971	1.0	0	0	0.5991073300781835	0.09707410587749266	FCGR3B;HLA-DPA1
Chronic myeloid leukemia	1/76	0.855664977625182	1.0	0	0	0.5242189138184106	0.08171333651133907	TGFB3
Pertussis	1/76	0.855664977625182	1.0	0	0	0.5242189138184106	0.08171333651133907	LY96
Antigen processing and presentation	1/77	0.8593015621680623	1.0	0	0	0.5174108759766131	0.07845778274454958	HLA-DPA1
Apelin signaling pathway	2/137	0.8618007836206728	1.0	0	0	0.5816151452583825	0.08650428622277946	GNB4;PRKAG1
Insulin signaling pathway	2/137	0.8618007836206728	1.0	0	0	0.5816151452583825	0.08650428622277946	PRKAR1A;PRKAG1
Cardiac muscle contraction	1/78	0.8628466978952991	1.0	0	0	0.5107774032076821	0.07534898471247646	COX7B
MAPK signaling pathway	5/295	0.8660009844799571	1.0	0	0	0.6752650415288001	0.0971498640066612	NGFR;TGFB3;RASGRF2;RAC3;DUSP8
RNA degradation	1/79	0.8663026800680461	1.0	0	0	0.5043118664582177	0.07237930122333443	EXOSC3
Signaling pathways regulating pluripotency of stem cells	2/139	0.8671915862261027	1.0	0	0	0.5732465820172548	0.08168497266982135	WNT10B;FZD2
Herpes simplex virus 1 infection	9/492	0.8728510471197819	1.0	0	0	0.7287921484792537	0.09910870631329771	EIF2B2;ZNF528;ZNF286B;FADD;ZNF577;ZNF841;EIF2S1;HLA-DPA1;ZNF662
ECM-receptor interaction	1/82	0.8761578026281833	1.0	0	0	0.48586143231950246	0.06423528533791374	HSPG2
Adrenergic signaling in cardiomyocytes	2/145	0.882226480548956	1.0	0	0	0.5495260337958511	0.06885917036412045	CREB3;PPP2CB
PI3K-Akt signaling pathway	6/354	0.8824883329613972	1.0	0	0	0.6752650415288001	0.08441468748897236	NGFR;PPP2CB;CREB3;LPAR6;GNB4;YWHAH
Proteoglycans in cancer	3/201	0.8834859014573081	1.0	0	0	0.5946363798537194	0.07366352200345452	WNT10B;FZD2;HSPG2
ErbB signaling pathway	1/85	0.8852878103896793	1.0	0	0	0.4687133817670494	0.05710919960791411	NRG4
Salmonella infection	1/86	0.8881793293082287	1.0	0	0	0.463263226165107	0.054934498730392675	ARPC1A
Phospholipase D signaling pathway	2/148	0.8891397590046303	1.0	0	0	0.5383869925702596	0.06326092742287764	LPAR6;CXCR2
Gap junction	1/88	0.8937459568530709	1.0	0	0	0.4527345164795364	0.05085734733109013	TUBA1B
Oxytocin signaling pathway	2/153	0.8998314707282914	1.0	0	0	0.5207926464078327	0.05496851180299882	PRKAG1;MYL6B
Dilated cardiomyopathy (DCM)	1/91	0.9015815914703503	1.0	0	0	0.4378092027494418	0.04535910603250648	TGFB3
Morphine addiction	1/91	0.9015815914703503	1.0	0	0	0.4378092027494418	0.04535910603250648	GNB4
Th1 and Th2 cell differentiation	1/92	0.9040631369423302	1.0	0	0	0.4330504070673826	0.0436757661867386	HLA-DPA1
Small cell lung cancer	1/93	0.9064822321299167	1.0	0	0	0.4283939510774108	0.042061367218392445	TRAF1
Regulation of actin cytoskeleton	3/214	0.907381554827244	1.0	0	0	0.5585136091149421	0.05428318843768476	ARPC1A;RAC3;ARHGEF4
Amoebiasis	1/96	0.9133803062434931	1.0	0	0	0.41500664010624166	0.037600821462903514	TGFB3
Hematopoietic cell lineage	1/97	0.9155648976767288	1.0	0	0	0.4107282211360742	0.03623199149536744	HLA-DPA1
Prostate cancer	1/97	0.9155648976767288	1.0	0	0	0.4107282211360742	0.03623199149536744	CREB3
Aldosterone synthesis and secretion	1/98	0.9176944982016408	1.0	0	0	0.4065371168387673	0.03491777151750455	CREB3
Phosphatidylinositol signaling system	1/99	0.919770489225787	1.0	0	0	0.4024306813151435	0.03365572389000244	INPP5E
AGE-RAGE signaling pathway in diabetic complications	1/100	0.9217942177900161	1.0	0	0	0.398406374501992	0.032443534443628054	TGFB3
C-type lectin receptor signaling pathway	1/104	0.9293922802364643	1.0	0	0	0.38308305240576157	0.028051014612928093	CD209
Th17 cell differentiation	1/107	0.9346032229514122	1.0	0	0	0.37234240607662805	0.02518270850787982	HLA-DPA1
NOD-like receptor signaling pathway	2/178	0.940275103083423	1.0	0	0	0.447647611799991	0.02756738604270629	FADD;CAMP
Alcoholism	2/180	0.9427328301044422	1.0	0	0	0.4426737494466578	0.02610551375582982	CREB3;GNB4
Serotonergic synapse	1/113	0.943901700536862	1.0	0	0	0.3525720128336213	0.020355127823518563	GNB4
Thyroid hormone signaling pathway	1/116	0.9480436178366249	1.0	0	0	0.3434537711224069	0.018324896074108216	NCOA2
Calcium signaling pathway	2/188	0.9516352868246751	1.0	0	0	0.42383656861914043	0.02101102808681884	CYSLTR1;ORAI3
Platelet activation	1/124	0.9576565879675721	1.0	0	0	0.3212954633080581	0.013901180102473955	SNAP23
Focal adhesion	2/199	0.961743735915029	1.0	0	0	0.4004084165849166	0.015618831442633895	RAC3;PARVB
Epstein-Barr virus infection	2/201	0.9633495617426214	1.0	0	0	0.39642425323581293	0.014802061638443567	FADD;HLA-DPA1
Rap1 signaling pathway	2/206	0.9670860439184225	1.0	0	0	0.3868023053417398	0.012945424987471654	NGFR;RAC3
Spliceosome	1/134	0.9672153805925419	1.0	0	0	0.2973181899268597	0.009910827621992465	PPIL1
Ubiquitin mediated proteolysis	1/137	0.969638389933844	1.0	0	0	0.29080757262919127	0.008966199689492428	UBA3
cAMP signaling pathway	2/212	0.9710875644998399	1.0	0	0	0.3758550702848981	0.011027074737008669	CREB3;RAC3
Fluid shear stress and atherosclerosis	1/139	0.9711535845744476	1.0	0	0	0.2866232910086274	0.008389650505670324	RAC3
Neuroactive ligand-receptor interaction	4/338	0.9719336026962695	1.0	0	0	0.4714868337301681	0.01342218667964496	CHRNB1;CYSLTR1;LPAR6;GPR83
Cellular senescence	1/160	0.983153238607638	1.0	0	0	0.24900398406374502	0.004230647975235804	TGFB3
cGMP-PKG signaling pathway	1/166	0.9855543235372916	1.0	0	0	0.240003840061441	0.003492303338552794	CREB3
MicroRNAs in cancer	2/299	0.9958355938394992	1.0	0	0	0.26649255819531237	0.0011121004806743287	MIR221;GLS2
